GeneticsAgent

GeneticsAgent is an AI-powered specialist that systematically evaluates the human genetic evidence supporting therapeutic targets by integrating data from biobanks, GWAS, rare disease cohorts, population sequencing, and functional genomics resources.

It identifies causal disease associations, assesses loss- and gain-of-function evidence, evaluates natural human knockouts and safety liabilities, and synthesizes genetic evidence into standardized confidence scores and actionable recommendations for target identification and validation.

What it does

• Causal disease associations — mines biobanks and GWAS to link genes/variants to disease with directional and effect-size context.
• Loss- and gain-of-function evidence — assesses whether reducing or increasing target activity is protective or deleterious.
• Natural human knockouts — evaluates predicted loss-of-function (pLoF) carriers in population sequencing to gauge tolerability of target inhibition.
• Safety liabilities — flags pleiotropy, essential-gene constraint, and adverse phenotypes associated with the target.
• Confidence scoring — synthesizes the above into a standardized, comparable genetic-evidence score.
• Actionable recommendations — outputs prioritized guidance for target identification and validation.

Data sources

Category	Examples
Biobanks	UK Biobank, FinnGen, All of Us
GWAS	GWAS Catalog, Open Targets Genetics
Rare disease cohorts	ClinVar, OMIM, DECIPHER
Population sequencing	gnomAD (constraint, pLoF)
Functional genomics	Open Targets Platform, expression/eQTL resources

Status

Early development. Interfaces and scoring methodology are subject to change.

License

TBD.